5-year urinary and sexual outcomes after radical prostatectomy: results from the Prostate Cancer Outcomes Study.

PubWeight™: 2.16‹?› | Rank: Top 2%

🔗 View Article (PMID 18405749)

Published in J Urol on May 01, 2008

Authors

David F Penson1, Dale McLerran, Ziding Feng, Lin Li, Peter C Albertsen, Frank D Gilliland, Ann Hamilton, Richard M Hoffman, Robert A Stephenson, Arnold L Potosky, Janet L Stanford

Author Affiliations

1: Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California 90089, USA. penson@usc.edu

Articles citing this

Surgical practice patterns for male urinary incontinence: analysis of case logs from certifying American urologists. J Urol (2012) 2.20

Validation study of a web-based assessment of functional recovery after radical prostatectomy. Health Qual Life Outcomes (2010) 1.42

The 5-year functional outcomes after radical prostatectomy: a real-life experience in Korea. Asian J Androl (2010) 1.42

Penile vibratory stimulation in the recovery of urinary continence and erectile function after nerve-sparing radical prostatectomy: a randomized, controlled trial. BJU Int (2014) 1.40

Erectile dysfunction following prostatectomy: prevention and treatment. Nat Rev Urol (2009) 1.24

Intraoperative fluorescence imaging of peripheral and central nerves through a myelin-selective contrast agent. Mol Imaging Biol (2012) 0.96

Long-term continence outcomes in men undergoing radical prostatectomy for clinically localized prostate cancer. Eur Urol (2013) 0.95

Detrusor underactivity is prevalent after radical prostatectomy: A urodynamic study including risk factors. Can Urol Assoc J (2013) 0.89

Patients' and urologists' preferences for prostate cancer treatment: a discrete choice experiment. Br J Cancer (2013) 0.88

Hypogonadism in male cancer patients. J Cachexia Sarcopenia Muscle (2012) 0.85

Neural differentiation of rat adipose-derived stem cells in vitro. Cell Mol Neurobiol (2012) 0.85

Treatment-related toxicity and symptom-related bother following postoperative radiotherapy for prostate cancer. Can Urol Assoc J (2010) 0.84

Effect of an adipose-derived stem cell and nerve growth factor-incorporated hydrogel on recovery of erectile function in a rat model of cavernous nerve injury. Tissue Eng Part A (2012) 0.83

Phosphodiesterase type 5 inhibitors for the treatment of post-nerve sparing radical prostatectomy erectile dysfunction in men. Sci Rep (2014) 0.82

Penile rehabilitation following prostate cancer treatment: review of current literature. Asian J Androl (2015) 0.81

Exploring the feasibility and acceptability of couple-based psychosexual support following prostate cancer surgery: study protocol for a pilot randomised controlled trial. Trials (2014) 0.81

Infrequent Reservoir-Related Complications of Urologic Prosthetics: A Case Series and Literature Review. Sex Med (2015) 0.81

Postprostatectomy Erectile Dysfunction: A Review. World J Mens Health (2016) 0.81

Tadalafil in the treatment of erectile dysfunction. Ther Clin Risk Manag (2008) 0.79

Short-, Intermediate-, and Long-term Quality of Life Outcomes Following Radical Prostatectomy for Clinically Localized Prostate Cancer. Rev Urol (2013) 0.78

Counseling patients about sexual health when considering post-prostatectomy radiation treatment. Int J Impot Res (2009) 0.77

Improved Intraoperative Visualization of Nerves through a Myelin-Binding Fluorophore and Dual-Mode Laparoscopic Imaging. PLoS One (2015) 0.76

Perioperative complications of radical retropubic prostatectomy in patients with locally advanced prostate cancer: a comparison with clinically localized prostate cancer. Asian J Androl (2012) 0.76

Continence rate and oncological feasibility after total transurethral resection of the prostate as an alternative therapy for the treatment of prostate cancer: a pilot study. Int Neurourol J (2011) 0.75

Patients' perceptions of the negative effects following different prostate cancer treatments and the impact on psychological well-being: a nationwide survey. Br J Cancer (2017) 0.75

Comparing Argus sling and artificial urinary sphincter in patients with moderate post-prostatectomy incontinence. J Exerc Rehabil (2014) 0.75

Erectile dysfunction in robotic radical prostatectomy: Outcomes and management. Indian J Urol (2014) 0.75

Commentary on urinary and sexual outcomes after radical prostatectomy. J Urol (2008) 0.75

Conservative treatment for postprostatectomy incontinence. Rev Urol (2013) 0.75

A Retrospective Study of Erectile Function and Use of Erectile Aids in Prostate Cancer Patients After Radical Prostatectomy in Denmark. Sex Med (2017) 0.75

Threat of Sexual Disqualification: The Consequences of Erectile Dysfunction and Other Sexual Changes for Gay and Bisexual Men With Prostate Cancer. Arch Sex Behav (2016) 0.75

Articles by these authors

A draft sequence of the rice genome (Oryza sativa L. ssp. indica). Science (2002) 42.78

Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science (2011) 13.16

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst (2005) 13.00

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. J Natl Cancer Inst (2006) 9.91

Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med (2013) 9.44

Early detection of prostate cancer: AUA Guideline. J Urol (2013) 9.14

Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med (2013) 7.95

Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res (2002) 7.11

Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. J Clin Oncol (2004) 7.02

Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med (2011) 6.89

Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels. Cell (2012) 6.83

Pivotal evaluation of the accuracy of a biomarker used for classification or prediction: standards for study design. J Natl Cancer Inst (2008) 6.79

Stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: comparison of toxicity. J Clin Oncol (2014) 6.62

Diagnostic markers for early detection of ovarian cancer. Clin Cancer Res (2008) 6.47

Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. J Natl Cancer Inst (2009) 6.07

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet (2009) 6.04

Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst (2004) 5.84

Survival following primary androgen deprivation therapy among men with localized prostate cancer. JAMA (2008) 5.66

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58

Outcomes of localized prostate cancer following conservative management. JAMA (2009) 5.57

Rapid synthesis of auxin via a new tryptophan-dependent pathway is required for shade avoidance in plants. Cell (2008) 5.55

Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis. Cancer Cell (2007) 5.09

Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study. Lancet Oncol (2008) 4.72

Integrating the predictiveness of a marker with its performance as a classifier. Am J Epidemiol (2007) 4.59

Trends in Metastatic Breast and Prostate Cancer--Lessons in Cancer Dynamics. N Engl J Med (2015) 4.58

Regulation of PTEN by Rho small GTPases. Nat Cell Biol (2005) 4.51

Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology (2009) 4.50

Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet (2016) 4.49

Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation. Am J Respir Crit Care Med (2009) 4.44

Active surveillance for prostate cancer: a systematic review of the literature. Eur Urol (2012) 4.24

Prostate specific antigen best practice statement: 2009 update. J Urol (2009) 3.95

Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat Genet (2013) 3.87

Risk profiles and treatment patterns among men diagnosed as having prostate cancer and a prostate-specific antigen level below 4.0 ng/ml. Arch Intern Med (2010) 3.85

Mortality after radical prostatectomy or external beam radiotherapy for localized prostate cancer. J Natl Cancer Inst (2013) 3.81

Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer. Ann Intern Med (2013) 3.74

Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity. J Natl Cancer Inst (2012) 3.72

Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. Clin Chem (2005) 3.71

A testing framework for identifying susceptibility genes in the presence of epistasis. Am J Hum Genet (2005) 3.69

Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet (2011) 3.68

Directional sensing requires G beta gamma-mediated PAK1 and PIX alpha-dependent activation of Cdc42. Cell (2003) 3.66

Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology (2003) 3.58

Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol (2009) 3.58

Evaluating the predictiveness of a continuous marker. Biometrics (2007) 3.54

A simple genetic architecture underlies morphological variation in dogs. PLoS Biol (2010) 3.46

Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene. Am J Hum Genet (2009) 3.41

Physical activity levels before and after a diagnosis of breast carcinoma: the Health, Eating, Activity, and Lifestyle (HEAL) study. Cancer (2003) 3.25

Comparative effectiveness of prostate cancer treatments: evaluating statistical adjustments for confounding in observational data. J Natl Cancer Inst (2010) 3.24

National Institutes of Health State-of-the-Science Conference statement: preventing alzheimer disease and cognitive decline. Ann Intern Med (2010) 3.24

Active surveillance for early-stage prostate cancer: review of the current literature. Cancer (2008) 3.18

Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming. Cell (2013) 3.13

Contemporary open and robotic radical prostatectomy practice patterns among urologists in the United States. J Urol (2012) 3.12

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet (2011) 3.07

Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst (2003) 3.07

Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma. Cancer (2002) 3.05

Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. Clin Chem (2002) 3.05

Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium. Cancer Epidemiol Biomarkers Prev (2008) 3.05

Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst (2005) 2.99

Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline. J Clin Oncol (2009) 2.95

Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer. JAMA (2010) 2.93

Physical activity levels among breast cancer survivors. Med Sci Sports Exerc (2004) 2.88

Lung cancer risk among female textile workers exposed to endotoxin. J Natl Cancer Inst (2007) 2.87

Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study. J Clin Oncol (2008) 2.85

Health effects of the 2003 Southern California wildfires on children. Am J Respir Crit Care Med (2006) 2.81

Statin use and risk of prostate cancer: results from a population-based epidemiologic study. Am J Epidemiol (2008) 2.79

5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study. J Urol (2005) 2.72

Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet (2011) 2.70

Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study. Clin Cancer Res (2013) 2.70

A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection. Biostatistics (2003) 2.69

A genome-wide association meta-analysis identifies new childhood obesity loci. Nat Genet (2012) 2.60

Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Cancer Res (2002) 2.56

Quality of life following localized prostate cancer treated initially with androgen deprivation therapy or no therapy. J Natl Cancer Inst (2002) 2.54

Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut. BMJ (2002) 2.52